TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Karo Pharma AS
Closing information (x1000 EUR)
Closing information | 2019/12 | 2018/12 | 2017/12 |
Turnover |
44,922
|
45,860
|
40,339 |
Financial expenses |
132
|
151
|
75 |
Earnings before taxes |
7,516
|
11,803
|
7,581 |
Total assets |
30,546
|
29,618
|
25,364 |
Current assets |
24,328
|
19,947
|
14,646 |
Current liabilities |
16,844
|
16,740
|
13,072 |
Equity capital |
13,442
|
12,591
|
11,862 |
- share capital |
689
|
678
|
691 |
Employees (average) |
22
|
21
![]() |
21 |
Shareholders | 0 | 0 | 0 |
Financial ratios
Fiscal year | 2019/12 | 2018/12 | 2017/12 |
Solvency |
44.0%
|
42.5%
|
46.8% |
Turnover per employee |
2,042
|
2,184
|
1,921 |
Profit as a percentage of turnover |
16.7%
|
25.7%
|
18.8% |
Return on assets (ROA) |
25.0%
|
40.4%
|
30.2% |
Current ratio |
144.4%
|
119.2%
|
112.0% |
Return on equity (ROE) |
55.9%
|
93.7%
|
63.9% |
Change turnover |
-1,715
|
6,283
|
-283 |
Change turnover % |
-4%
|
16%
|
-1% |
Chg. No. of employees |
1
|
0
|
-9 |
Chg. No. of employees % |
5%
|
0%
|
-30% |
Total value of public sale
Fiscal year | 2019/12 | 2018/12 | 2017/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.